(2022) have recently reported the effects of another ORAI1 inhibitor, CM5480 (CalciMedica Inc.)in duct cells, both in vitro and in vivo, using alcohol‐ or bile‐induced AP (Fig. 1). The gene discussed is ORAI1; the disease is alkaline phosphatase measurement.